To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs
U GRO Capital is a listed MSME lending fintech platform
Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production
Phase 2a clinical proof-of-concept biomarker study for PXL065 in ALD now anticipated to start midyear
Suvinys Developers will supply dydrogesterone to Jagsonpal Pharma as per the terms and conditions mentioned in the agreement.
Brian joins LEO Pharma from Novo Nordisk, U.S. where he served as Senior Vice President of Sales.
Companies plan to commercialize breath-based detection of lung infection and transplant rejection
Research collaboration covers multiple antibody research programs
The MoU was signed on World Organ Donation Day which falls on August 13
The collaboration of two strong partners, CELLINK and UPM, builds confidence in making these treatments into an industrial and clinical standard, applied in a wider setting instead of remaining only within few hospitals.
Subscribe To Our Newsletter & Stay Updated
